Integrated Diagnosis and Treatment of CKD on Outcomes

Objective: To establish a study cohort and follow up of patients with CKD in our hospital, and evaluate the status of integrated CKD diagnosis and treatment according to guidelines in the real world, as well as the clinical prognosis of patients with different stratification.

Methods: By establishing a cohort of 1000 patients with CKD and conducting long-term follow-up, integrated diagnosis and treatment for CKD was performed, namely: Regular monitoring, control of blood pressure, blood glucose, blood lipid, correction of anemia, minerals - bone metabolic abnormalities, malnutrition, acid and alkali, and electrolyte disorder, diet and exercise, such as the guidance of integrated management, non intrusive, observational studies, prospective cohort were analyzed retrospectively, describe the implementation of the integration of diagnosis and treatment, chronic kidney disease (CKD) Stratified analysis and risk factor analysis were performed for cardiovascular disease and other main endpoint events, so as to objectively reflect the status of integrated treatment of CKD and provide data support for continuous quality improvement of CKD diagnosis and treatment and improvement of clinical prognosis of patients.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Chronic Kidney Diseases Anemia Avitaminosis Bone Diseases Bone Diseases, Metabolic Calcium Metabolism Disorders Cardiovascular Diseases Chronic Disease Chronic Kidney Disease-Mineral and Bone Disorder Deficiency Diseases Disease Attributes Dyslipidemias Endocrine System Diseases Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Glucose Metabolism Disorders Hematologic Diseases Hemic and Lymphatic Diseases Hyperglycemia Hyperlipidemias Hyperparathyroidism Hyperparathyroidism, Secondary Hypertension Kidney Diseases Lipid Metabolism Disorders Male Urogenital Diseases Malnutrition Metabolic Diseases Musculoskeletal Diseases Nutrition Disorders Nutritional and Metabolic Diseases Parathyroid Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Renal Insufficiency Renal Insufficiency, Chronic Rickets Urogenital Diseases Urologic Diseases Vascular Diseases Vitamin D Deficiency

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Nephrology Department of Beijing Jishuitan Hospital

Beijing, Beijing Municipality, 100035, China

Location status: Recruiting

Location contact

Dongliang Zhang, Director

CONTACT

[email protected]

+860150963534

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

≥18 years old;
Voluntarily signed informed consent;
Patients who are estimated to develop CKD.

Exclusion criteria

Age < 18 or ≥100 years;
Unable to comply with the procedures stipulated in this study;
Estimated follow-up time ≤6 months.

Treatment and study plan

Integrated diagnosis and treatment for CKD

Other

This is an observational study. Investor will not intervene the clinical practice of doctors. In the real world, there would be many factors affect the proceeding of the guidelines contents. There will be integrated diagnosis and treatment during follow-up.

Primary outcomes

Rate of cardiovascular cerebrovascular adverse events

Time frame: Six months or more

Acute myocardial infarction, heart failure, shock, cardiac arrest, stroke, and lower limb arterial occlusion occurred during follow-up

Secondary outcomes

Rate of all-cause mortality

Time frame: Six months or more

Deaths from all causes during follow-up

Sponsors and collaborators

Lead sponsor

Capital Medical University

Other

Registry information

Official study title

A Prospective, Cohort, and Observational Study of the Effect of Integrated Diagnosis and Treatment of Chronic Kidney Disease (CKD) on Clinical Outcomes in Real World Clinical Practice

Important dates

Study start: 2022
Primary completion: 2026
Study completion: 2026
First posted: Feb 16, 2022
Registry last updated: May 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed